Udai Banerji

33PUBLICATIONS
224CO-AUTHORS
Molecular targetsPredictive and prognostic markersAutoimmunityTumour immunologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 11, 2026
Phase I safety, efficacy, and biomarker response evaluations of three oral PD-L1 inhibitors: INCB086550, INCB099280, and INCB099318.

|Jun 24, 2026
Virtual Tumors Enable Prediction of Personalized Therapeutic Combinations for Non-Small Cell Lung Cancer.

|May 23, 2026
Safety and Efficacy of HexaBody-DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed Hepatotoxicity.

|Apr 27, 2026
Phase I Trial of Ipatasertib plus Atezolizumab Enhances PI3K/AKT Pathway Immune Responses in Solid Tumors and Refractory Glioblastoma.

|Aug 27, 2025
Proteomic Landscapes of 3D and 2D Models of High-Grade Serous Ovarian Carcinoma: Implications for Carboplatin Response.

Jimmy Maillard, Theodoros I Roumeliotis, Ekta Paranjape

|Aug 25, 2025
A retrospective study of the impact of comorbidity, polypharmacy and demographic factors on patient inclusion and healthcare delivery in phase I oncology trials.

Hoda Nemat, Martin Orr, Lucy Barrow

Pageof 6

Frequent Collaborators

5 joint publications

Nina Tunariu

5 joint publications

Ruth Ruddle

5 joint publications

Karen Swales

5 joint publications

Anna Minchom